We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychi... Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19 pediatric epilepsy. Show more
Immedica Pharma AB (Immedica), a leading global rare disease company, and Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company committed to improving the lives of patients with...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0079 | 1.49084732968 | 0.5299 | 0.5427 | 0.51 | 8601146 | 0.52811115 | CS |
4 | 0.2485 | 85.8969927411 | 0.2893 | 0.5427 | 0.2202 | 2937898 | 0.44106962 | CS |
12 | -1.2622 | -70.1222222222 | 1.8 | 1.96 | 0.2202 | 3470112 | 0.39997876 | CS |
26 | -0.6822 | -55.9180327869 | 1.22 | 1.97 | 0.2202 | 1862252 | 0.57322245 | CS |
52 | -10.2522 | -95.015755329 | 10.79 | 11.26 | 0.2202 | 1627591 | 1.48465745 | CS |
156 | -10.7922 | -95.253309797 | 11.33 | 12.37 | 0.2202 | 866383 | 3.75187491 | CS |
260 | -1.4722 | -73.2437810945 | 2.01 | 20.04 | 0.2202 | 1076376 | 4.13995197 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions